PEspeaks

May 09, 2018
Pharmaceutical Executive
The pharmaceutical industry needs to be paying more attention to consumer purchase habits.
May 08, 2018
Pharmaceutical Executive
John Cervione, managing partner of Blue Fin Group, talks briefly about Amazon’s foray into the healthcare and pharma industries.
May 08, 2018
Pharmaceutical Executive
Amid new efforts to inspire more physicians to engage their patients about clinical research, turning that vision into tangible gains in trial participation remains tricky.
May 07, 2018
Pharmaceutical Executive
FDA officials are mapping plans to restructure the Office of New Drugs (OND) in the Center for Drug Evaluation and Research (CDER), writes Jill Wechsler.
May 03, 2018
Read more for details of how to nominate a colleague or yourself for Pharm Exec's Emerging Pharma Leaders 2018.
May 02, 2018
From BioPharm International
Public health authorities and the biomedical research community are seeking new strategies to address global health threats, writes Jill Wechsler.
Apr 27, 2018
Pharmaceutical Executive
Insights from Partnering with IDNs: Biopharma Strategy Summit.
Apr 24, 2018
Pharmaceutical Executive
This blog post focuses on digital process automation challenges of PV Intake, with an emphasis on the elements required to fully process an ICSR and influence upstream adverse event case processing (AECP) through the application of digital automation.
Apr 23, 2018
Jin Zhang discusses the research and development of several major biologics in China.
Apr 10, 2018
Pharmaceutical Executive
This op-ed discusses the varying skills that business leaders should look at in scientists when thinking about talent for the lab and the executive suite.
native1_300x100
lorem ipsum